Quick Eye Scan Helps Tell Two Serious Optic Nerve Conditions Apart

Credibility

Interest

Key Takeaway

A quick eye scan (OCT) in the first two weeks can often tell MOGAD optic neuritis apart from NMOSD optic neuritis, helping doctors decide treatment sooner.

What They Found

Researchers looked at 111 adults who had their first episode of optic neuritis and had an OCT eye scan within 2 weeks of symptoms. They measured thickness of the layer of nerve fibers around the optic disc (pRNFL) — thicker measurements often mean swelling or disc edema, like a swollen garden hose where the nerve fibers run. Most MOGAD eyes (about 73%) showed clear swelling on OCT, while only about 11% of NMOSD eyes did, so swelling was much more common with MOGAD. A pRNFL value above 117.5 micrometers was a good cutoff: it correctly identified NMOSD vs MOGAD most of the time (high specificity and good sensitivity). Swelling was not linked to antibody levels, body weight, or small delays to scanning, but it tended to be stronger when both eyes were affected at the same time in MOGAD.

Who Should Care and Why

People with MS-like optic nerve attacks and their caregivers should care because OCT is a quick, noninvasive test that can help tell which disease is more likely right away — like using a thermometer to help decide if someone needs urgent treatment. Neurologists and eye doctors benefit because early distinction matters: NMOSD often needs faster, more aggressive treatment (for example plasma exchange), while MOGAD usually shows more swelling and a different course. For patients, this means an early OCT could speed up the right treatment choice and possibly protect vision, similar to catching a leak early before it causes more damage. Caregivers can use this info to ask for an OCT if a sudden vision problem appears, especially within the first two weeks. Clinics that see sudden vision loss should consider adding early OCT to their checklist the same way emergency rooms check vital signs.

Important Considerations

This study looked only at people with the first optic neuritis attack and only within two weeks, so results might not apply later on or after repeat attacks. The research compared groups with MOGAD and NMOSD, not classic MS, so OCT findings may differ for MS-related optic neuritis. Finally, while OCT helps guide early decisions, antibody tests and the full clinical picture are still important before final treatment choices are made.

Categories:

MS Diagnostics Specific Symptoms Early Research

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Neurology(R) neuroimmunology & neuroinflammation often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News